SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-311726
Filing Date
2020-12-07
Accepted
2020-12-07 16:00:55
Documents
12
Period of Report
2020-12-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d13395d8k.htm   iXBRL 8-K 33967
  Complete submission text file 0001193125-20-311726.txt   156972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA galt-20201203.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20201203_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20201203_pre.xml EX-101.PRE 11424
5 EXTRACTED XBRL INSTANCE DOCUMENT d13395d8k_htm.xml XML 3470
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 201372716
SIC: 2834 Pharmaceutical Preparations